Michael Cross, MD
Orthopaedic Surgery · Indianapolis, INNPI 1235397043
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.6%), royalties or licence payments and speaking fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Depuy Synthes Products, Inc. at 33.8% of the total. Reporting peaked in 2023 at $204,216 and has fallen 61.4% since, to $78,736 in 2025. Among orthopaedic surgery clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 480 payments — averaging $1813.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Depuy Synthes Products, Inc.$294K
- Medical Device Business Services, Inc.$205K
- KCI USA, Inc.$116K
- Encore Medical, LP$90K
- Smith+Nephew$58K
- Pacira Therapeutics, Inc.$47K
- plus $61K from 12 others
Across 8 payments — averaging $2622.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- KCI USA, Inc.$16K
- Exactech, Inc.$5K
Across 7 payments — averaging $17,910 each. An ownership or investment interest held by the physician or an immediate family member.
- Intellijoint Surgical Inc.$125K
What the payments were for
- Royalty or licence$211,46824%
- Consulting fees$397,12446%
- Speaking & faculty fees$101,33812%
- Travel & lodging$59,6917%
- Food & beverage$10,1891%
- Education$5500%
- Gifts$1140%
- Other$89,78210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Depuy Synthes Products, Inc. | 111 | $294,116 |
| Medical Device Business Services, Inc. | 132 | $204,879 |
| KCI USA, Inc. | 68 | $115,897 |
| Encore Medical, LP | 1 | $89,782 |
| Smith+Nephew | 51 | $57,522 |
| Pacira Therapeutics, Inc. | 38 | $47,153 |
| Exactech, Inc. | 33 | $26,535 |
| Linkbio Corp | 8 | $20,324 |
| Solventum Corporation | 7 | $10,137 |
| Alphatec Spine, Inc | 2 | $2,000 |
| Johnson & Johnson | 14 | $959 |
| Zimmer Biomet | 5 | $362 |
| Medacta USA, Inc. | 3 | $216 |
| Engage Uni, LLC | 1 | $114 |
| Stryker | 2 | $108 |
| Avanos Medical | 1 | $99 |
| Medtronic | 2 | $30 |
| My01 Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ATTUNE$241,058
- PREVENA$121,243
- Zilretta$46,753
- Journey II$35,102
- REAL INTELLIGENCE$28,369
- PREVENA RESTOR ARTHROFORM$23,946
- TRULIANT$22,115
- K-15 PORK$21,994
- V.A.C. VERAFLO$18,147
- POLARSTEM$14,143
- REDAPT$13,777
- OR3O Dual Mobility$12,363
- R3 ACETABULAR$12,003
- RI.HIP NAVIGATION$11,948
- PREVENA RESTOR ARTHO-FORM$11,580
- PREVENA RESTOR AXIO-FORM$11,580
- PREVENA RESTOR ROTO-FORM$11,580
- Legion$11,500
- Prevena Restor Bella Form$11,330
- Tandem$10,853
How this compares
$870,255 in reported general payments places this provider in the 95th percentile of 400 orthopaedic surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 62 | $31,871 |
| Diclofenac Sodium | 271 | $2,719 |
| Oxycodone Hcl | 322 | $1,979 |
| Cefadroxil | 162 | $1,794 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 38 | $374 |
| Celecoxib | 29 | $318 |
| Doxycycline Hyclate | 19 | $208 |
| Meloxicam | 48 | $198 |
| Tramadol Hcl | 51 | $177 |
| Ondansetron OdtOndansetron | 12 | $139 |
| Gabapentin | 18 | $127 |
| Amoxicillin | 54 | $111 |
| Cephalexin | 35 | $54 |
| Clindamycin Hcl | 13 | $16 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Indianapolis
- David FisherIndianapolis$5.9M
- Michael BerendIndianapolis$4M
- Sanford KunkelIndianapolis$1.9M
- Hill HastingsIndianapolis$1.6M
- Brian MullisIndianapolis$632K
- Dean MaarIndianapolis$589K
- Russell SwannIndianapolis$135K
- Thomas FischerIndianapolis$117K
- Wesley LackeyIndianapolis$115K
- Mark DillonIndianapolis$98K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.